Subsequently, we assessed the expression of granulocytic differentiation markers (CD11b, CD11c and CD18) in NB4 cells treated with ATRA for 48 hours, to confirm the role of NEAT1 in modulating differentiation in APL cells. Here, ITGB2 is linked to acute promyelocytic leukemia.